Filing Details
- Accession Number:
- 0001123292-18-000756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-23 17:05:33
- Reporting Period:
- 2018-05-21
- Accepted Time:
- 2018-05-23 17:05:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1230057 | Herm Rosenman | C/O Vivus, Inc. 900 E. Hamilton Ave., Suite 550 Campbell CA 95008 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-21 | 75,000 | $0.70 | 136,671 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-05-21 | 100,000 | $0.81 | 236,671 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-05-21 | 75,000 | $0.00 | 75,000 | $0.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 75,000 | 2024-10-27 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7839 to $0.8248, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- One twelfth (1/12th) of the total number of shares subject to the option shall vest and become exercisable on the 27th of each month following October 27, 2017, subject to such individual continuing to be a Service Provider (as defined in the 2010 Equity Incentive Plan) on the relevant vesting dates.
Billionaire Hedge Funds
